Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Curium US Holdings LLC has entered into a definitive agreement to merge with Lantheus Holdings, Inc. The transaction values Lantheus at up to $8 billion. Shareholders will receive $102.50 per share plus potential additional cash payments. This merger aims to enhance theranostic solutions and expand services globally.
Company Information
Company
Curium Pharma
Location
Paris, Ile De France, France
About
Curium is a world leader in nuclear medicine. We develop, manufacture, and distribute world-class radiopharmaceutical products to help patients around the globe. Our proven heritage combined with a pioneering approach are the hallmarks to deliver innovation, excellence, and unparalleled service.
Paris
BedfordManufacturingBiotechnologyHealth CareBiotechnologyHealth CareTherapeutics